Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PENTASA DIN 02153521

Status: Marketed
Holder: FERRING INC
Molecule: MESALAZINE
Available to quote

Health Canada record

Active ingredient(s)MESALAZINE 1 G
Dosage formSuspension
RouteRectal
SchedulePRESCRIPTION
ClassHuman
ATCA07EC02 MESALAZINE
Original market date31-Dec-1995
Current status date09-Nov-1999
SourceHealth Canada DPD

Establishment licence of the holder

Ferring Inc. — licence 100274, currently licensed, last inspection rating C (2026-05-19).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MESALAZINE

DINProductCompanyFormStrengthStatus
02552426MESALAMINETILLOTTS PHARMA AGTablet (Delayed-Release)MESALAZINE 800 MGApproved
02297558MEZAVANTTAKEDA CANADA INCTablet (Delayed- And Extended-Release)MESALAZINE 1.2 GMarketed
02524481MEZERAAVIR PHARMA INC.Tablet (Delayed-Release)MESALAZINE 500 MGMarketed
02545012MEZERAAVIR PHARMA INC.Tablet (Delayed-Release)MESALAZINE 1 GMarketed
02474018MEZERAAVIR PHARMA INC.SuppositoryMESALAZINE 1 GMarketed
02474026MEZERAAVIR PHARMA INC.FoamMESALAZINE 1 GMarketed
02529610OCTASATILLOTTS PHARMA AGTablet (Delayed-Release)MESALAZINE 1600 MGMarketed
02465752OCTASATILLOTTS PHARMA AGTablet (Delayed-Release)MESALAZINE 800 MGMarketed
02265257PENDO-5 ASAPENDOPHARM DIVISION OF PHARMASCIENCE INCTablet (Enteric-Coated)MESALAZINE 400 MGApproved
02399466PENTASAFERRING INCTablet (Extended-Release)MESALAZINE 1 GMarketed
02099683PENTASAFERRING INCTablet (Extended-Release)MESALAZINE 500 MGMarketed
02153556PENTASAFERRING INCSuspensionMESALAZINE 4 GMarketed
02153564PENTASAFERRING INCSuppositoryMESALAZINE 1 GMarketed
02242146SALOFALKABBVIE CORPORATIONSuppositoryMESALAZINE 1000 MGMarketed
02112809SALOFALKABBVIE CORPORATIONSuspensionMESALAZINE 4 GMarketed
02112795SALOFALKABBVIE CORPORATIONSuspensionMESALAZINE 2 GMarketed
02112787SALOFALKABBVIE CORPORATIONTablet (Delayed-Release)MESALAZINE 500 MGMarketed
02112760SALOFALKABBVIE CORPORATIONSuppositoryMESALAZINE 500 MGMarketed
02171929TEVA-5 ASATEVA CANADA LIMITEDTablet (Enteric-Coated)MESALAZINE 400 MGMarketed
02562367ZDS-MESALAMINE SUPPOSITORIESZYDUS LIFESCIENCES LIMITEDSuppositoryMESALAZINE 1000 MGMarketed
023514635-ASASANIS HEALTH INCTablet (Enteric-Coated)MESALAZINE 400 MGCancelled Post Market
01997580ASACOLALLERGAN INCTablet (Enteric-Coated)MESALAZINE 400 MGCancelled Post Market
02267217ASACOL 800ALLERGAN INCTablet (Delayed-Release)MESALAZINE 800 MGCancelled Post Market
01914030MESASALGLAXOSMITHKLINE INCTablet (Enteric-Coated)MESALAZINE 500 MGCancelled Post Market
02348063NTP-5-AMINOSALICYLIC ACIDTEVA CANADA LIMITEDTablet (Enteric-Coated)MESALAZINE 400 MGCancelled Pre Market
02153548PENTASA ENEMA 2G/100MLFERRING INCEnema; LiquidMESALAZINE 2 GCancelled Post Market
02099675PENTASA EXTENDED-RELEASE TABLETS 250MGFERRING INCTablet (Extended-Release)MESALAZINE 250 MGCancelled Post Market
02112779SALOFALK (R) 5-ASA ENTERIC COATED TAB- 250MGAXCAN PHARMA INCTablet (Enteric-Coated)MESALAZINE 250 MGCancelled Post Market
02112752SALOFALK (R) 5-ASA SUPPOSITORIES - 250MGAXCAN PHARMA INCSuppositoryMESALAZINE 250 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
15601999-11-08Supplement to a New Drug Submission (SNDS)CHANGE IN PRODUCT NAME
48721995-02-27Supplement to a New Drug Submission (SNDS)CHANGE IN PRODUCT NAME, REVISED LABELLING

International API supply for MESALAZINE

19 valid EDQM Certificates of Suitability from 19 holders. 1 active FDA Drug Master Files.

Request a quote for PENTASA

How to read a Canadian DIN record